Indian drug giant Cipla slashes cancer drug prices
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
May 4, 2012
0
0